Jan Holst
51 – 60 of 61
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 1994
-
Mark
Effect of low molecular weight heparin, dextran and their combinations on experimental venous thrombosis in rabbits
(
- Contribution to journal › Article
-
Mark
Protamine neutralization of intravenous and subcutaneous low-molecular-weight heparin (tinzaparin, Logiparin(TM)). An experimental investigation in healthy volunteers
(
- Contribution to journal › Article
-
Mark
Antithrombotic effect of recombinant truncated tissue factor pathway inhibitor (TFPI1-161) in experimental venous thrombosis : A comparison with low molecular weight heparin
(
- Contribution to journal › Article
- 1993
-
Mark
Tissue factor pathway inhibitor (TFPI) and its response to heparin in patients with spontaneous deep vein thrombosis
(
- Contribution to journal › Article
- 1992
-
Mark
Effect on primary haemostasis of prophylactic regimens of low molecular weight heparin, unfractionated heparin, dextran and their combinations. An animal experimental study
(
- Contribution to journal › Article
- 1988
-
Mark
Interleukin-1 potentiates glucose stimulated insulin release in the isolated perfused pancreas
(
- Contribution to journal › Article